EPISODE · Apr 6, 2023 · 7 MIN
Thursday, April 6, 2023
from The Gist Healthcare Podcast
The FTC orders gene-sequencing company Illumina to divest cancer-test developer Grail. The hospital industry pushes back against likely nursing home staff mandates in an upcoming CMS proposed rule. And, Mark Cuban’s prescription drug company will sell brand-name diabetes drugs for the first time. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
The FTC orders gene-sequencing company Illumina to divest cancer-test developer Grail. The hospital industry pushes back against likely nursing home staff mandates in an upcoming CMS proposed rule. And, Mark Cuban’s prescription drug company will sell brand-name diabetes drugs for the first time. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
Thursday, April 6, 2023
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m